MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-75-0010436
Pramila Pharmaceuticals Private Limited
Pramila Pharmaceuticals Private Limited - healthcare in Varanasi, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.02 Cr
▼ 2% YoY
Net profit · FY 2025
₹38,663
Net margin 0.4%
EBITDA · FY 2025
₹2.14 Lakh
EBITDA margin 2.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹15 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Pramila Pharmaceuticals Private Limited
Data last updated:
Pramila Pharmaceuticals Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 15 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74999UP2018PTC100282. Its GSTIN is 09AAJCP6374Q1ZE (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rohit Tripathi and Preeti Srivastava.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Varanasi, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.02 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹38,663 (net margin 0.4%) and EBITDA of ₹2.14 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 40% over five years.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
Pramila Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-75-0010436). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999UP2018PTC100282
Registration Number 100282
Incorporation Date 15 January 2018
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-75-0010436
Recognitions & Rankings of Pramila Pharmaceuticals
Contact details
Pramila Pharmaceuticals Private Limited's registered office is in Varanasi, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No – Rm 11/10 Ground Floor Shop No – 2, Mujza – Kakarmatta Pargana Dehat Amanat Near Little Flower House School, Varanasi, Uttar Pradesh, India – 221004
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Pramila Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Pramila Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Pramila Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pramila Pharmaceuticals Private Limited, buy the company report.
Financials of Pramila Pharmaceuticals Private Limited
FY 2025 filings availablePramila Pharmaceuticals Private Limited reported revenue of ₹1.02 Cr (down 2% YoY) for FY 2025.
Revenue · FY 2025
₹1.02 Cr ▼ 2%
Net profit · FY 2025
₹38,663 margin 0.4%
EBITDA · FY 2025
₹2.14 Lakh margin 2.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 5%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▲ 340%
3 years · compounded
▲ 64%
5 years · compounded
▲ 53%
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 40%. EBITDA rose 340% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.14 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹38,663 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pramila Pharmaceuticals Private Limited, buy the company report.
Board of directors of Pramila Pharmaceuticals Private Limited
Pramila Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohit Tripathi | Director | 15 Jan 2018 | 8 Years 9 Months | Current |
| Preeti Srivastava | Additional Director | 04 Feb 2026 | 0 Years 9 Months | Current |
Peer comparison
Pramila Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| 4Life Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2025) | 22.0% | Jaipur, Rajasthan, India | |||
| Chemspirit Instruments & Technologies Private Limited | ₹1.02 Cr (FY 2024) | -8.0% | Selaiyur, Tamil Nadu, India | |||
| Medigenesis Pharma Private Limited | ₹1.02 Cr (FY 2024) | 20.0% | Delhi, India | |||
| Alleviate Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2025) | -8.0% | Panchkula, Haryana, India | |||
| Pramila Pharmaceuticals Private Limitedthis company | ₹1.02 Cr (FY 2025) | ₹38,663 | 0.4% | -2.0% | Varanasi, Uttar Pradesh, India | |
| Vitkains Pharmaceuticals Private Limited | ₹1.02 Cr (FY 2025) | 10.0% | Jabalpur, Madhya Pradesh, India |
To see the full peer comparison of Pramila Pharmaceuticals Private Limited, buy the company report.
Auditor
Pramila Pharmaceuticals Private Limited is audited by SRDS & Company, Chartered accountant for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SRDS & Company, Chartered accountant | FY 2023 | 0017961C |
Shareholding
The shareholding of Pramila Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pramila Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jan 2023 | 100684251 | Uco Bank | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Pramila Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pramila Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pramila Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAJCP6374Q1ZE | Uttar Pradesh | Active | 14 Mar 2018 |
To see the full GST registrations and return filing status of Pramila Pharmaceuticals Private Limited, buy the company report.
Recent activity
Pramila Pharmaceuticals Private Limited has 6 board changes on record since 2018: 4 appointments and 2 cessations. The latest: Pramila Srivastava ceased to be Director on 04 Feb 2026.
Ceased
Pramila Srivastava ceased to be Director.
Appointed
Preeti Srivastava was appointed as Additional Director.
AGM
Pramila Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Pramila Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Ceased
Tarit Kumar Srivastava ceased to be Director.
Charges
A charge with Uco Bank amounted to Rs. 15.00 Lakh with Charge ID 100684251 was registered on 24 Jan 2023.
Appointed
Pramila Srivastava was appointed as Director.
Appointed
Rohit Tripathi was appointed as Director.
Appointed
Tarit Kumar Srivastava was appointed as Director.
Incorporation
15 Jan 2018
Pramila Pharmaceuticals Private Limited was registered on 15 Jan 2018 with Roc Uttar Pradesh I & aged 8 years 9 months as per MCA records.
Frequently asked questions
Pramila Pharmaceuticals is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 15 January 2018 (8+ years old) and is registered under CIN U74999UP2018PTC100282.
Pramila Pharmaceuticals has 2 current directors:
- Rohit Tripathi - Director
- Preeti Srivastava - Additional Director
The latest financial statements of Pramila Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Pramila Pharmaceuticals is 09AAJCP6374Q1ZE, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Pramila Pharmaceuticals is U74999UP2018PTC100282. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pramila Pharmaceuticals was incorporated on 15 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Pramila Pharmaceuticals by revenue are 4Life Pharmaceuticals Private Limited, Chemspirit Instruments & Technologies Private Limited, Medigenesis Pharma Private Limited, Alleviate Pharmaceuticals Private Limited, Vitkains Pharmaceuticals Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Pramila Srivastava ceased to be Director on 04 Feb 2026. Preeti Srivastava was appointed as Additional Director on 04 Feb 2026. Tarit Kumar Srivastava ceased to be Director on 08 Sep 2023. Pramila Pharmaceuticals has 6 board changes on record in total.
Yes, Pramila Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-75-0010436).
The registered office of Pramila Pharmaceuticals is at H.No – Rm 1110 Ground Floor Shop No – 2, Mujza – Kakarmatta Pargana Dehat Amanat Near Little Flower House School, Varanasi, Uttar Pradesh, India – 221004.
Pramila Pharmaceuticals operates in the healthcare industry, in the medical equipment retail and distribution segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages